Tech Company Financing Transactions

Bayhill Therapeutics Funding Round

De Novo Ventures, Morgenthaler Ventures and U.S. Venture Partners participated in a $54.3 million capital raise for Bayhill Therapeutics. The funding round was announced on 12/31/2008.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

1804 Embarcadero Rd. 201
Palo Alto, CA 94303
USA

Phone

(650) 320-2800

Website

www.bayhilltx.com

Email Address

[email protected]

Overview

Bayhill Therapeutics Inc. is focused on the translation of research into therapeutics by developing novel drugs for the treatment of autoimmune diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Operating Officer

Hideki Garren

        

VP - Finance

Kwang Lee

        

VP - Manufacturing

Robert King

        

VP - Regulatory Affairs

Joanne Quan

        

Browse more venture capital transactions:

Prev: 12/31/2008: HydraDx venture capital transaction
Next: 12/31/2008: Amorcyte venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary